 eYugoslavia.com | Heart failure treatment co Enopace Biomedical raises $7m Globes Italy's Sorin Group made the investment, saying that heart failure is the largest unmet medical need. Enopace Biomedical Ltd. has raised $7 million from Italian cardiovascular diseases medical devices company Sorin Group SlA (BIT: SRN). ... Sorin Group Invests in Enopace Biomedical, Early Stage Company Focused on ... |
